or Try an Advanced Search...

    Technical Analysis for CRSP - CRISPR Therapeutics AG

    Grade Last Price % Change Price Change
    F 40.68 0.94% 0.38
    CRSP closed up 3.23 percent on Thursday, January 16, 2025, on 85 percent of normal volume.
    8 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical CRSP trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.94%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.94%
    Multiple of Ten Bullish Other 0.94%
    Inside Day Range Contraction 0.94%
    Gapped Up Strength 0.94%
    20 DMA Resistance Bearish 4.20%
    Multiple of Ten Bearish Other 4.20%
    Gapped Up Strength 4.20%
    New 52 Week Closing Low Bearish 6.05%
    180 Bearish Setup Bearish Swing Setup 6.05%
    Older End-of-Day Signals for CRSP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Up 3% about 3 hours ago
    Up 2% about 3 hours ago
    Rose Above 20 DMA about 3 hours ago
    Rose Above Previous Day's High about 3 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    CRSP Chart by TradingView

    Profile

    Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine CRISPR DNA Genome Editing Cas9

    Is CRSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 16 2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
    Jan 16 My 10 Top Stocks to Buy to Start the New Year Off Right
    Jan 16 CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers
    Jan 15 CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)
    Jan 14 Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts
    Jan 13 CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
    Jan 9 3 Mid-Cap Stocks That Could Take Off in 2025
    Jan 8 CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
    Jan 7 CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
    Jan 7 CRISPR Therapeutics Proposes New Appointment to the Board of Directors
    See more CRSP news...

    Comments

    Indicators

    Indicator Value
    52 Week High 91.1
    52 Week Low 36.52
    Average Volume 1,892,375
    200-Day Moving Average 51.25
    50-Day Moving Average 45.86
    20-Day Moving Average 40.58
    10-Day Moving Average 40.43
    Average True Range 2.16
    RSI (14) 43.18
    ADX 18.42
    +DI 20.51
    -DI 26.78
    Chandelier Exit (Long, 3 ATRs) 38.86
    Chandelier Exit (Short, 3 ATRs) 43.00
    Upper Bollinger Bands 43.42
    Lower Bollinger Band 37.74
    Percent B (%b) 0.45
    BandWidth 14.01
    MACD Line -1.76
    MACD Signal Line -1.90
    MACD Histogram 0.14
    Fundamentals Value
    Market Cap 3.2 Billion
    Num Shares 79.4 Million
    EPS -4.47
    Price-to-Earnings (P/E) Ratio -9.02
    Price-to-Sales 34.65
    Price-to-Book 3.22
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 42.16
    Resistance 3 (R3) 42.08 41.38 41.85
    Resistance 2 (R2) 41.38 40.91 41.42 41.75
    Resistance 1 (R1) 40.84 40.61 41.11 40.92 41.64
    Pivot Point 40.14 40.14 40.28 40.18 40.14
    Support 1 (S1) 39.60 39.67 39.87 39.68 38.96
    Support 2 (S2) 38.90 39.37 38.94 38.85
    Support 3 (S3) 38.36 38.90 38.75
    Support 4 (S4) 38.44